| Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a … BJ Werth, G Sakoulas, WE Rose, J Pogliano, R Tewhey, MJ Rybak Antimicrobial agents and chemotherapy 57 (1), 66-73, 2013 | 147 | 2013 |
| Rapid detection of vancomycin-intermediate Staphylococcus aureus by matrix-assisted laser desorption ionization–time of flight mass spectrometry CA Mather, BJ Werth, S Sivagnanam, DJ SenGupta, SM Butler-Wu Journal of clinical microbiology 54 (4), 883-890, 2016 | 79 | 2016 |
| Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a … BJ Werth, R Jain, A Hahn, L Cummings, T Weaver, A Waalkes, ... Clinical Microbiology and Infection 24 (4), 429. e1-429. e5, 2018 | 78 | 2018 |
| Characterization of the mechanisms of daptomycin resistance among Gram-positive bacterial pathogens by multidimensional lipidomics KM Hines, A Waalkes, K Penewit, EA Holmes, SJ Salipante, BJ Werth, ... MSphere 2 (6), 10.1128/msphere. 00492-17, 2017 | 78 | 2017 |
| Observation of “seesaw effect” with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains KE Barber, CE Ireland, N Bukavyn, MJ Rybak Infectious diseases and therapy 3, 35-43, 2014 | 75 | 2014 |
| Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA BJ Werth, C Vidaillac, KP Murray, KL Newton, G Sakoulas, P Nonejuie, ... Antimicrobial agents and chemotherapy 57 (5), 2376-2379, 2013 | 73 | 2013 |
| Multidrug-resistant Corynebacterium striatum associated with increased use of parenteral antimicrobial drugs WO Hahn, BJ Werth, SM Butler-Wu, RM Rakita Emerging Infectious Diseases 22 (11), 1908, 2016 | 72 | 2016 |
| Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the “seesaw effect”: taking advantage of the back door left open? JK Ortwine, BJ Werth, G Sakoulas, MJ Rybak Drug Resistance Updates 16 (3-5), 73-79, 2013 | 71 | 2013 |
| Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in … BJ Werth, ME Steed, GW Kaatz, MJ Rybak Antimicrobial agents and chemotherapy 57 (6), 2664-2668, 2013 | 64 | 2013 |
| Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis BJ Werth, ME Steed, CE Ireland, TT Tran, P Nonejuie, BE Murray, ... Antimicrobial Agents and Chemotherapy 58 (9), 5253-5261, 2014 | 62 | 2014 |
| Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic … A Hall Snyder, BJ Werth, KE Barber, G Sakoulas, MJ Rybak Journal of Antimicrobial Chemotherapy 69 (8), 2148-2154, 2014 | 62 | 2014 |
| Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes KE Barber, BJ Werth, CE Ireland, NE Stone, P Nonejuie, G Sakoulas, ... Journal of Antimicrobial Chemotherapy 69 (11), 3006-3010, 2014 | 57 | 2014 |
| Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro … BJ Werth, KE Barber, CE Ireland, MJ Rybak Antimicrobial agents and chemotherapy 58 (6), 3177-3181, 2014 | 55 | 2014 |
| Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey J Seni, SG Mapunjo, R Wittenauer, R Valimba, A Stergachis, BJ Werth, ... BMJ open 10 (12), e042819, 2020 | 50 | 2020 |
| Emergence of high-level daptomycin resistance in Corynebacterium striatum in two patients with left ventricular assist device infections BJ Werth, WO Hahn, SM Butler-Wu, RM Rakita Microbial Drug Resistance 22 (3), 233-237, 2016 | 48 | 2016 |
| The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA KE Barber, BJ Werth, MJ Rybak Journal of Antimicrobial Chemotherapy 70 (2), 505-509, 2015 | 48 | 2015 |
| A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant … KE Barber, BJ Werth, JP McRoberts, MJ Rybak Antimicrobial agents and chemotherapy 58 (5), 2989-2992, 2014 | 48 | 2014 |
| Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model AD Hall Snyder, BJ Werth, P Nonejuie, JP McRoberts, J Pogliano, ... Antimicrobial Agents and Chemotherapy 60 (10), 5716-5723, 2016 | 47 | 2016 |
| Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and-resistant VRE BJ Werth, KE Barber, N Tran, P Nonejuie, G Sakoulas, J Pogliano, ... Journal of Antimicrobial Chemotherapy 70 (2), 489-493, 2015 | 45 | 2015 |
| Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus … ME Steed, BJ Werth, CE Ireland, MJ Rybak Antimicrobial agents and chemotherapy 56 (11), 5709-5714, 2012 | 40 | 2012 |
